The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Singapore
Sterile development and manufacturing
Thermo Fisher Scientific’s state-of-the-art sterile drug development and manufacturing facility in Singapore supports rapid fill finish vaccines and other therapeutics for an expanding biopharma market.
With support from the Singapore Economic Development Board, (EDB) this facility is an essential part of Thermo Fisher Scientific’s global network – now comprising of six facilities supporting aseptic manufacturing and sterile fill finish.
Our commitment to meeting scientists’ needs globally is further strengthened by this facility, which is designed to enhance our network for biomedical research, development, and commercialization.
Site Offerings
- The 24,000-sqaure-meter facility includes a high-speed, fully automated, aseptic fill-finish line for small and large molecules.
- Contains a single-use formulation system and custom scalability from small-scale process development to large clinical batches.
- Includes cleanroom capacity, labs, warehousing, and offices to support production.
- Carefully constructed with flexibility and scalability in mind – the potential for an additional 14,000 square meters of space to provide capacity for our customers’ growing needs.
- Additional space for filling lines and added capabilities for prefilled syringe & cartridges, filling line of smaller scale for process development and clinical trials, commercial sterile lyophilized lines and packaging.
To find out more about our unique site offerings, download our fact sheet below.
Capabilities
Existing Capabilities
- Jacketed tanks and disposable bag technology (Up to 1000L)
- Single use technologies and flexible facility design
- In house QC capabilities
- Sterile Liquids (SVP)
Biopharmaceuticals
- Commercial scale filling
- Process development / small scale filling
- Packaging
Expansion capabilities (not currently available)
- Sterile lyophilized products
- Prefilled syringes
- Prefilled catridges
Drug product dosage form
| Size / details | Early Development (into part of phase ll) | Late development | Commercial supply | |||||
|---|---|---|---|---|---|---|---|---|
| Liquid vials | ||||||||
| Lyophilized vials (Expansion) | ||||||||
| Prefilled syringes (Expansion) | ||||||||
| Prefilled cartridges (Expansion) | ||||||||
⬤ Available now
✱ Future capabilities
To learn more about this site or to request a site tour, please contact us below.
Helpful Resources
Infographic
10 reasons steriles manufacturing isn’t getting any easier
Download our infographic to uncover 10 key challenges in steriles development and manufacturing and see how an experienced, end-to-end CDMO partner like Thermo Fisher Scientific can help.
Whitepaper
Switching delivery formats: A lifecycle management strategy for sterile injectables
Switching delivery formats can be an effective strategy to enhance they lifecycle of your drug. This whitepaper provides insight into the benefits and challenges of transferring a therapeutic compound from one aseptic injectable format to another.
Location
Brisbane, AU: Clinical and Commercial Manufacturing
Our Brisbane, Australia site is 2014 winner of the ISPE Facility of the Year award and 2015 winner of the Frost and Sullivan APAC CMO of the year award.
Location
Singapore
The Singapore team works closely with clinical trial Sponsors to define the best distribution model for each study, realizing cost and performance efficiencies across the APAC supply chain.